{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T05:19:39Z","timestamp":1739596779100,"version":"3.37.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["316287\/2023-7"],"award-info":[{"award-number":["316287\/2023-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.841293\/2023-00"],"award-info":[{"award-number":["88887.841293\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The multifocality of actinic keratosis (AK), the unpredictability of lesion evolution with potential progression to squamous cell carcinoma (SCC), and the consequent risk of local extension and metastasis, alongside the recent development of new therapies, make the selection of a therapeutic regimen challenging. The increasing incidence of this condition is associated with economic costs and its impact on quality of life, which has fostered interest in studying protocols for treating this skin condition. The topical application of 16% methyl aminolevulinate (MAL) is well-established in the literature for its local therapeutic effects and ease of application. However, the high cost of medication, long incubation time, and adverse effects such as itching and burning in some patients limit the dissemination of this treatment. Studies are needed to test other protocols of this promising therapy to increase acceptance among patients and professionals. Therefore, the objective of this protocol is to compare the efficacy of the topical application of MAL at concentrations of 8% and 16%, mediated by red light, as well as to evaluate the impact of different incubation times (1 or 3 hours) in the treatment of actinic keratoses on the face, with a 6-month follow-up. This parallel-arm, 6-month follow-up randomized controlled, double-blind clinical protocol will consist of 4 groups: G1 - Control Group - MAL 16% irradiated with 643\u2009nm and 75 J\/cm<jats:sup>2<\/jats:sup> and 3-hour incubation time (n\u2009=\u200936), G2 - MAL 16% and 1-hour incubation (n\u2009=\u200936), G3 - MAL 8% - 3 hours (n\u2009=\u200936), and G4 - MAL 8% - 1 hour (n\u2009=\u200936). The primary outcome will be the complete remission of the lesion at six months. Secondary outcomes will include treatment success (75% reduction in the initial number of lesions), recurrence rate, emergence of SCC, incidence of adverse effects, and improvement in skin texture, wrinkles, and pigmentation using a validated scale. All outcomes will be assessed at 30 days, 3, and 6 months. At six months, quality of life will be assessed using the Actinic Keratosis Quality of Life questionnaire (AKQoL) and Face-Q. If data are normal, they will be subjected to 3-way ANOVA and presented as means \u00b1 standard deviation (SD). Otherwise, they will be presented as median and interquartile range and compared using the Kruskall-Wallis and Friedman tests. Categorical variables will be evaluated with the chi-square, Fisher\u2019s exact, or likelihood ratio tests. A p-value &lt; 0.05 will be considered significant.<\/jats:p>","DOI":"10.1371\/journal.pone.0318109","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:33:57Z","timestamp":1739558037000},"page":"e0318109","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of four regimens of methyl aminolevulinate mediated by red light to treat actinic keratoses: A randomized controlled clinical protocol"],"prefix":"10.1371","volume":"20","author":[{"given":"Ricardo Hideyoshi","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milene Alves","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao Paulo Ratto","family":"Tempestini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Pavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara Jansiski","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Kalil","family":"Bussadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen Sayuri","family":"Ando-Suguimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-9286","authenticated-orcid":true,"given":"Kristianne Porta","family":"Santos Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Agnelli","family":"Mesquita-Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthya Cosme","family":"Gutierrez Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-9064","authenticated-orcid":true,"given":"Anna Carolina Ratto Tempestini","family":"Horliana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"6","key":"pone.0318109.ref001","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1590\/abd1806-4841.20188802","article-title":"Profile of dermatological consultations in Brazil (2018)","volume":"93","author":"Sociedade Brasileira de Dermatologia","year":"2018","journal-title":"An Bras Dermatol"},{"issue":"8","key":"pone.0318109.ref002","doi-asserted-by":"crossref","first-page":"adv00128","DOI":"10.2340\/00015555-3486","article-title":"Actinic keratosis diagnosis and increased risk of developing skin cancer: a 10-year cohort study of 17,651 patients in Sweden","volume":"100","author":"G Guorgis","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"pone.0318109.ref003","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.abd.2021.08.011","article-title":"Cultural adaptation and validation of the quality of life questionnaire for patients with actinic keratosis (AKQoL-BR) to Brazilian Portuguese","volume":"97","author":"MA Haruno de Vilhena","year":"2022","journal-title":"An Bras Dermatol"},{"issue":"4","key":"pone.0318109.ref004","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1524-4725.2009.01096.x","article-title":"Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study","volume":"35","author":"RM Szeimies","year":"2009","journal-title":"Dermatol Surg"},{"issue":"11\u201312","key":"pone.0318109.ref005","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jbio.201600164","article-title":"Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: a comparative study","volume":"9","author":"CA Lima","year":"2016","journal-title":"J Biophotonics"},{"issue":"3","key":"pone.0318109.ref006","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ajd.12354","article-title":"Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia","volume":"57","author":"JA See","year":"2016","journal-title":"Australas J Dermatol"},{"issue":"1","key":"pone.0318109.ref007","first-page":"26","article-title":"O uso da terapia fotodin\u00e2mica com aminolevulinato de metila e luz do dia para tratamento de queratoses act\u00ednicas","volume":"11","author":"TA Mar\u00e7on","year":"2019","journal-title":"Surgical Cosmetic Dermatology"},{"issue":"2","key":"pone.0318109.ref008","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40266-022-00919-0","article-title":"Topical pharmacotherapy for actinic keratoses in older adults","volume":"39","author":"PG Calzavara-Pinton","year":"2022","journal-title":"Drugs Aging"},{"issue":"6","key":"pone.0318109.ref009","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1159\/000524745","article-title":"Long-term efficacy of photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus conventional two-stage topical methyl aminolevulinate for superficial basal-cell carcinoma","volume":"238","author":"LCJ Van Delft","year":"2022","journal-title":"Dermatology"},{"issue":"5","key":"pone.0318109.ref010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/jdv.14691","article-title":"Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries","volume":"32","author":"MC Fargnoli","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"pone.0318109.ref011","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.3390\/ijms24054989","article-title":"Pharmacological agents used in the prevention and treatment of actinic keratosis: a review","volume":"24","author":"D Arcuri","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0318109.ref012","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2011.02.011","article-title":"Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model","volume":"66","author":"I Zalaudek","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"pone.0318109.ref013","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.abd.2019.10.004","article-title":"Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects","volume":"94","author":"CP Reinehr","year":"2019","journal-title":"An Bras Dermatol"},{"key":"pone.0318109.ref014","first-page":"39","article-title":"Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer","volume":"3","author":"JL Cohen","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"pone.0318109.ref015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0365-05962012000300012","article-title":"Actinic keratosis: a clinical and epidemiological revision","volume":"87","author":"JV Schmitt","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"19","key":"pone.0318109.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms231911351","article-title":"Topical treatment of actinic keratosis and metalloproteinase expression: a clinico-pathological retrospective study","volume":"23","author":"E Campione","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0318109.ref017","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/bjd.12343","article-title":"Network meta-analysis of the outcome \u201cparticipant complete clearance\u201d in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review","volume":"169","author":"AK Gupta","year":"2013","journal-title":"Br J Dermatol"},{"key":"pone.0318109.ref018","first-page":"CD004415","article-title":"Interventions for actinic keratoses","volume":"12","author":"AK Gupta","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"pone.0318109.ref019","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2009.09119.x","article-title":"Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial","volume":"160","author":"SR Wiegell","year":"2009","journal-title":"Br J Dermatol"},{"key":"pone.0318109.ref020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2008.03029.x","article-title":"Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses","volume":"23","author":"LR Braathen","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 Pt 1","key":"pone.0318109.ref021","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","article-title":"A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck","volume":"24","author":"EA Olsen","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"pone.0318109.ref022","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/lsm.22665","article-title":"Red light photodynamic therapy for actinic keratosis using 37 J\/cm2: Fractionated irradiation with 12.3 mW\/cm2 after 30 minutes incubation time compared to standard continuous irradiation with 75 mW\/cm2 after 3 hours incubation time using a mathematical modeling","volume":"49","author":"AS Vignion-Dewalle","year":"2017","journal-title":"Lasers Surg Med"},{"issue":"10","key":"pone.0318109.ref023","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa1811850","article-title":"Randomized trial of four treatment approaches for actinic keratosis","volume":"380","author":"MHE Jansen","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0318109.ref024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3959(86)90228-9","article-title":"The measurement of clinical pain intensity: a comparison of six methods","volume":"27","author":"MP Jensen","year":"1986","journal-title":"Pain"},{"key":"pone.0318109.ref025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.sjpain.2016.06.012","article-title":"How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance","volume":"13","author":"GZ Heller","year":"2016","journal-title":"Scand J Pain"},{"issue":"1","key":"pone.0318109.ref026","first-page":"11","article-title":"Paracetamol: mechanism of action, applications and safety concern","volume":"71","author":"M J\u00f3\u017awiak-Bebenista","year":"2014","journal-title":"Acta Pol Pharm"},{"issue":"1","key":"pone.0318109.ref027","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14764170410003075","article-title":"Combination radiofrequency and diode laser for treatment of facial rhytides and skin laxity","volume":"7","author":"SN Doshi","year":"2005","journal-title":"J Cosmet Laser Ther"},{"issue":"24","key":"pone.0318109.ref028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bjd.12036","article-title":"Assessing the influence of actinic keratosis on patients\u2019 quality of life: the AKQoL questionnaire","volume":"168168","author":"S Esmann","year":"2013","journal-title":"Br J DermatolBr J Dermatol"},{"issue":"6","key":"pone.0318109.ref029","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.abd.2021.08.011","article-title":"Cultural adaptation and validation of the quality of life questionnaire for patients with actinic keratosis (AKQoL-BR) to Brazilian Portuguese","volume":"97","author":"MA Haruno de Vilhena","year":"2022","journal-title":"An Bras Dermatol"},{"issue":"4","key":"pone.0318109.ref030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0030-1262313","article-title":"Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q","volume":"26","author":"AF Klassen","year":"2010","journal-title":"Facial Plast Surg"},{"issue":"7","key":"pone.0318109.ref031","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/asj\/sjv244","article-title":"Patient perceived benefit in facial aesthetic procedures: FACE-Q as a tool to study botulinum toxin injection outcomes","volume":"36","author":"Bl Chang","year":"2016","journal-title":"Aesthet Surg J"},{"issue":"2","key":"pone.0318109.ref032","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/PRS.0000000000001412","article-title":"Face-lift satisfaction using the FACE-Q","volume":"136","author":"S Sinno","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"pone.0318109.ref033","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PRS.0000000000003164","article-title":"Validating facial aesthetic surgery results with the FACE-Q","volume":"139","author":"EA Kappos","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"pone.0318109.ref034","volume-title":"FACE-Q - Satisfaction with Facial Appearance Overall \u2013 tradu\u00e7\u00e3o para a l\u00edngua portuguesa do Brasil, adapta\u00e7\u00e3o cultural e valida\u00e7\u00e3o [tese]","author":"JT Gama","year":"2018"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:34:16Z","timestamp":1739558056000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318109"}},"subtitle":[],"editor":[{"given":"Liang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318109","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}